Silk Road Science City "three years out of the image" • industrial energy level jumped
Giant Bio, a global leader in recombinant collagen
Xi'an Juzi Biogene Technology Co., Ltd., located in the Silk Road Science City of High-tech Zone, is a biotechnology enterprise based on scientific and technological aesthetics. In November 2022, the company was successfully listed on the main board of the Hong Kong Stock Exchange, becoming the "first recombinant collagen stock" in mainland China and the "leader" among the 13 listed companies since the planning and construction of the Silk Road Science City.
With the industrialization of active natural product manufacturing, medical repair dressings and high-end medical devices and other projects starting construction in the Silk Road Science City, Juzi Biotech has brought cutting-edge technology from the laboratory to life, providing a strong source of power for the development of new quality productivity.
National Engineering Research Center for Biomaterials and Industrialization Project of Human-like Collagen Biomaterials
R&D and innovation empower the high-quality cultivation of "industrial chain clusters".
Nowadays, the biomedical industry of the Silk Road Science City is bursting with vitality, the construction of professional parks is accelerating, the R&D capabilities are becoming more and more mature, innovative products with international competitiveness continue to emerge, and the energy level of the industrial chain is constantly rising.
"Basic research is the leader of technological progress, and this is closer to the truth than ever before." As the world's first leading enterprise to realize the mass production of recombinant collagen skin care products, Juzi Biotech not only fills the gap in the field of collagen research in China and brings "Chinese ingredients" to the world, but also promotes the extension of the biomedical industry chain in the Silk Road Science City with its industrial application.
Quality-based "industrialization practice" continues to expand
In December 2021, the industrialization project of Juzi biomedical repair dressings and high-end medical devices started construction in the Silk Road Science City. The construction area of the project is 71,300 square meters, mainly producing Class II and Class III medical dressings and high-end medical devices. The project is scheduled to be put into use in December 2024 and will create more than 300 jobs. After the completion of the project, the scale of high-end medical devices will be expanded, to meet the market demand for human-like collagen-like medical devices in various industries, and to effectively enhance the international competitiveness of mainland biogene technology.
Renderings of Juzi biomedical repair dressings and high-end medical device industrialization projects
Juzi Bioactive Natural Products Manufacturing Industrialization Project, with a construction area of 58,600 square meters, mainly produces preventive medicine and nutritional medicine products. The project will start construction in March 2023 and is scheduled to be put into use in 2025, which will lead to the employment of more than 300 people. After the completion of the project, it will build a platform for achievement transformation and product research and development in the fields of biotechnology and functional food, and accelerate the industrialization process in the field of biomedical engineering in China.
Renderings of the industrialization of the manufacture of bioactive natural products of Juzi
Climb higher and higher The "new consumer market" continues to grow
Scientific research and innovation are the "fulcrum" of Juzi Biotech and the "lever" to leverage the steady development of the enterprise.
Between 2000 and 2009, Giant Biotech has developed dozens of different types of recombinant collagen and successfully achieved mass production. As of March 2024, Giant Biotech has more than 10 tons of recombinant collagen production capacity and more than 200 tons of production capacity under construction. Its recombinant collagen technology was granted the first patent in the industry in China, and won the second prize of the National Technological Invention Award and the China Patent Gold Award in 2013 and 2016, respectively.
Xi'an Juzi Biogene Technology Co., Ltd
With "independent recombinant collagen ingredients + self-developed type proportioning technology + mass production capacity", Juzi Biotech has basically achieved "self-sufficiency" in the whole process, and has successively established 8 independent brands, including Fumei, Kelijin, Kepre, Kexing, Keping, Meiyume, SKIGIN and ginseng glycoside, and has developed hundreds of products covering functional skin care products, medical dressings, skin rejuvenation products and functional foods, leading the new trend of "collagen skin care" and winning the favor of consumers in all circles. In response to the call of the municipal government, Juzi Biotech has continuously optimized its industrial structure, enhanced its core competitiveness, continuously increased R&D investment, launched more new raw materials and products, consolidated its position as a "global leader in recombinant collagen", built a new blueprint for biotechnology to create beauty and health, and contributed to the high-quality development of Xi'an's "Eight New Breakthroughs".
Empower science and technology innovation and move towards the new. As the core bearing area of "double centers", the Silk Road Science City has steadily promoted the leap of the biomedical industry from "enterprise cultivation" to "industrial cultivation", accelerated the growth of new quality productivity with industrial changes in the critical period of harvest and growth, and built a new pattern of development of the biomedical industry with the opportunity of "double centers".